课题基金 / 基金详情

Tanzanian Drug Treatment as AIDS Prevention - Reliability and Validity Study

Tanzanian Drug Treatment as AIDS Prevention - Reliability and Validity Study
坦桑尼亚药物治疗作为艾滋病预防 - 可靠性和有效性研究
批准号:
8300392
负责人:
Mark L Williams
金额:
$14.16万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-15 至 2012-08-31

项目摘要

项目成果

Mark L Williams的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):本研究的目的是坦桑尼亚药物治疗作为艾滋病毒/艾滋病预防项目(D-TAPP)--可靠性和有效性研究,旨在进行必要的形成性研究,以在坦桑尼亚达累斯萨拉姆实施药物治疗作为艾滋病毒预防干预措施。D-TAPP 1)-信度和效度研究的具体目的是:目的1:制定心理功能、社会功能、治疗动机、成瘾严重程度和治疗准备程度的文化适宜性测量;目标2:评估注射吸毒者对心理功能、社会功能、治疗动机、成瘾严重程度和治疗准备程度测量的理解和相关性;以及目标3:检验D-TAPP问卷的信度和效度。D-TAPP-信度和效度研究将分三个部分实施,反映三个具体目标,采用混合方法设计。在构成部分1中,D-TAPP调查问卷将从英语翻译成斯瓦希里语,翻译的准确性和翻译后的措施的内容有效性将由讲斯瓦希里语的专家小组评估。在构成部分2中,半结构化访谈数据将从40名注射吸毒者的有目的样本中收集。在这一部分,D-TAPP问卷将提供给IDU参与者,并要求他们评估问卷中每个项目的可理解性和文化相关性(目标2)。参与者还将被要求评估用于记录测量反应的量表。特别是,注射吸毒者将被要求提出建议,以改善可理解性、文化相关性和反应衡量。将对调查表进行修改,以反映构成部分2研究的结果。第三部分将评估这些措施的心理测量学。内部和48小时测试/重测的可靠性将与内容、结构和标准相关的效度一起确定。在这项研究中,有目的的样本150名注射吸毒者将被招募参与。数据将在入院时和48小时后收集。公共卫生相关性:坦桑尼亚药物治疗作为艾滋病毒/艾滋病预防项目(D-TAPP)-可靠性和有效性研究将调查坦桑尼亚注射吸毒者样本中标准化治疗动机测量的心理测量学特性。
英文摘要
DESCRIPTION (provided by applicant): The purpose of this study, the Tanzanian Drug Treatment as HIV/AIDS Prevention Project (D-TAPP) - Reliability and Validity Study, is to conduct formative research necessary to the implement of drug treatment as an HIV prevention intervention in Dar es Salaam, Tanzania. The specific aims of D-TAPP 1) - Reliability and Validity Study are: Aim1: To develop culturally appropriate measures of psychological functioning, social functioning, treatment motivation, addiction severity, and readiness for treatment; Aim 2: To assess IDUs' understanding and relevancy of the measures of psychological functioning, social functioning, treatment motivation, addiction severity, and readiness for treatment; and Aim 3: To test the reliability and validity of the D-TAPP Questionnaire. The D-TAPP - Reliability and Validity Study will be implemented in three components reflecting the three specific aims using a mixed methods design. In component 1, the D-TAPP questionnaire will be translated from English to Swahili and the accuracy of the translations and the content validity of the translated measures will be assessed by a panel of native Swahili-speaking experts. In component 2, semi-structured interview data will be collected from a purposeful sample of 40 IDUs. In this component, the D-TAPP questionnaire will be presented to IDU participants, and they will be asked to assess the understandability and cultural relevancy of each item in the questionnaire (Aim 2). Participants will also be asked to evaluate scales used to record measurement responses. In particular, IDUs will be asked to make recommendations that will improve understandability, cultural relevancy, and response measurement. The questionnaire will be modified to reflect findings produced by the Component 2 study. Component 3 will assess the psychometrics of the measures. Internal and 48 hour test/retest reliability will be determined along with content, construct and criterion related validities. For this study, a purposeful sample of 150 IDUs will be recruited to participate. Data will be collected at intake and 48 hours later. PUBLIC HEALTH RELEVANCE: Tanzanian Drug Treatment as HIV/AIDS Prevention Project (D-TAPP) - Reliability and Validity Study will investigate the psychometric properties of standardized measures of treatment motivation in a sample of Tanzanian injection drug users.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigator Development Core
  • 批准号:
    10436490
  • 项目类别:
  • 资助金额:
    $60.46万
  • 财政年份:
    2021
  • 负责人:
    Mark L Williams
  • 依托单位:
Investigator Development Core
  • 批准号:
    10494200
  • 项目类别:
  • 资助金额:
    $59.33万
  • 财政年份:
    2021
  • 负责人:
    Mark L Williams
  • 依托单位:
Investigator Development Core
  • 批准号:
    10657711
  • 项目类别:
  • 资助金额:
    $58.92万
  • 财政年份:
    2021
  • 负责人:
    Mark L Williams
  • 依托单位:
Tanzanian Drug Treatment as AIDS Prevention - Reliability and Validity Study
国内基金
海外基金
不同功能基团的电中性Drug-Free纳米颗粒的构建及克服肿瘤耐药的研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    杨胜彩
  • 依托单位:
Drug-ADR-Pathway复合网络构建及ADR分子机制研究
  • 批准号:
    61372188
  • 项目类别:
    面上项目
  • 资助金额:
    80.0万元
  • 批准年份:
    2013
  • 负责人:
    陈秀杰
  • 依托单位:
Drug-pHLA对接指纹图谱库的构建及HLA介导SADR的预测方法研究
  • 批准号:
    61073135
  • 项目类别:
    面上项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2010
  • 负责人:
    梅虎
  • 依托单位:
新型药物传输系统drug-LDHs 复合纳米粒子的可控制备及其微结构对缓控释性能的调控
  • 批准号:
    20776012
  • 项目类别:
    面上项目
  • 资助金额:
    31.0万元
  • 批准年份:
    2007
  • 负责人:
    张慧
  • 依托单位: